Cystic fluid biomarkers for the differential diagnosis of inflammatory and non-inflammatory cystic pancreatic lesions (Neutrophil gelatinase-associated lipocalin (NGAL); Interleukin 1 Beta(IL 1β); High-mobility group AT-hook 2(HmgA2))-Reference-Cited by-同舟云学术

Cystic fluid biomarkers for the differential diagnosis of inflammatory and non-inflammatory cystic pancreatic lesions (Neutrophil gelatinase-associated lipocalin (NGAL); Interleukin 1 Beta(IL 1β); High-mobility group AT-hook 2(HmgA2))

Published:2023-04 Issue: Volume: Page:
ISSN:1438-8812
Container-title:ESGE Days 2023
language:
Short-container-title:

Author:

Olar M. P.¹,Seicean R.²,Iacobescu M.³,Iuga C. A.⁴³,Bolboaca S. D.⁵,Rusu I.⁶,Mosteanu O.⁶,Sparchez Z.⁷,Pojoga C.⁸,Nadim A. H.⁹,Seicean A.⁷

Affiliation:

1. University of Medicine and Pharmacy "Iuliu Haţieganu", Cluj-Napoca, Romania

2. First Department of Surgery, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania

3. Research Center for Advanced Medicine MedFUTURE, University of Medicine and Pharmacy, Cluj-Napoca, Romania

4. Drug analysis, Department Pharmacy 3, Faculty of Pharmacy, University of Medicine and Pharmacy, Cluj-Napoca, Romania

5. Department of Medical Informatics and Biostatistics,University of Medicine and Pharmacy, Cluj-Napoca, Romania

6. Regional Institute of Gastroenterology and Hepatology Prof. O. Fodor, Cluj-Napoca, Romania

7. Department of Gastroenterology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania

8. Regional Institute of Gastroenterology and Hepatology Prof. Dr. O. Fodor, Cluj-Napoca, Romania

9. Third Department of Surgery, Iuliu Hatieganu Univeristy of Medicine and Pharmacy, Cluj-Napoca, Romania

Publisher

Georg Thieme Verlag KG

Reference5 articles.

1. Diagnosis and management of pancreatic cystic neoplasms: current evidence and guidelines;NC M van Huijgevoort;Nature reviews Gastroenterology & hepatology,2019

2. Clinical Practice Guidelines for the Endoscopic Management of Peripancreatic Fluid Collections;C H Oh;Clin Endosc,2021

3. The Role of Interleukin 1 Beta in Differentiating Malignant from Benign Pancreatic Cysts;M Kaddah;J Interferon Cytokine Res.,2022

4. Cystic fluid neutrophil gelatinase-associated lipocalin (NGAL) concentration in differential diagnosis of pancreatic cystic lesions: a new factor enters the scene?;M Lipinski;Prz Gastroenterol,2018

5. Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance;S H Chiou;Sci Rep,2018